retatrutide type 2 diabetes phase 2 results 2024 ada 💉 A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with diabetes, a new 3 trial shows. is part of an emerging generation Remission of type 2 diabetes:

Over the last several years, GLP-1 prescriptions have surged because these drugs are widely discussed not only for diabetes control but also for weight loss and long-term chronic weight management, including use patterns that expanded public awareness and demand

However, similar to Ex-4, the responsiveness of liraglutide differs between AD models

As of April 2026, two trials have read out and seven more are expected to report through the year, with NDA filing targeted for Q4 2026

Similar to the observation in myocytes, the top predicted ligands for upregulated genes included TGF1 and WNT5b, while predicted ligands for downregulated genes included TGF1 and slc6a8 ( note: different genes in the TGF 1 pathway were enriched amongst down-versus up-regulated genes following semaglutidethis is unsurprising, as cytokines like TGF 1 induce gene suppression as well as activation, and the effects of semaglutide impact both vectors of transcriptional change )

65 , S630S631 (2013)